FMC Slashes Q3 Guidance: Revenue to $65M-$125M, EBITDA Deeply Negative on $625M+ Channel Actions

What happened

FMC has updated third-quarter 2026 expectations to revenue of $65 million to $125 million and Adjusted EBITDA of negative $565 million to negative $510 million, driven by comprehensive commercial actions that will incur approximately $625 million to $675 million in charges impacting revenue and EBITDA. Management claims these actions will accelerate product movement through the channel and support future replenishment demand. This latest guidance drastically undershoots even the most bearish scenarios from the prior DeepValue report, which already flagged covenant stress, negative operating cash flow, and heavy reliance on receivables monetization. The scale of these charges suggests the channel is far more clogged than previously disclosed, and the actions are effectively buying future demand at the cost of current profitability.

Implication

Investors should treat this as confirmation that FMC's balance-sheet and cash-flow problems are worsening, not stabilizing. The commercial actions may clear the channel but at a massive cost that further erodes equity value and covenant headroom. Avoid averaging down; wait for evidence that operating cash flow turns positive without additional financial engineering.

Thesis delta

The investment thesis shifts decisively negative. The prior base case assumed collections would normalize and free cash flow would land near zero in 2026; this update shows the company is paying hundreds of millions in charges just to move product through the channel, meaning true cash generation is likely far worse than guided. The bull case, which hinged on cost reductions offsetting price declines, is now highly unlikely to materialize in the near term. The bear case probability increases materially, with an implied value below current levels.